😎 Summer Sale Exclusive - Up to 50% off AI-powered stock picks by InvestingProCLAIM SALE

Merck KGaA says larger-scale acquisitions an option from 2023

Published 10/06/2022, 02:18 AM
Updated 10/06/2022, 03:00 AM
© Reuters. FILE PHOTO: A cyclist drives past a logo of drugs and chemicals group Merck KGaA in Darmstadt, Germany January 28, 2016.  REUTERS/Ralph Orlowski

By Ludwig Burger

FRANKFURT (Reuters) -German diversified healthcare and chemicals group Merck KGaA said it would begin to look into larger takeover deals next year after having reduced its debt.

"As of 2023, the Group will once again consider potential larger-scale acquisitions as an option," the company said in a statement ahead of an investor day on Thursday.

The group's most recent major takeover was that of Versum Materials, a maker of chemicals for semiconductor production, for 5.8 billion euros ($5.7 billion) in 2019.

Net debt to adjusted core earnings was cut to a multiple of about 1.2 this year, down from 2.8 in 2019, and the company was approaching "financial capacity" of around 15 to 20 billion euros, according to presentation slides posted on its website.

© Reuters. FILE PHOTO: A cyclist drives past a logo of drugs and chemicals group Merck KGaA in Darmstadt, Germany January 28, 2016.  REUTERS/Ralph Orlowski

The group with close to 20 billion euros in revenues last year reaffirmed its goal to add more than 1 billion euros in sales every year through 2025, thanks to ongoing investments in new manufacturing and services sites.

($1 = 1.0096 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.